BlackRock Institutional Trust’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.02M Sell
3,960
-62
-2% -$46.9K ﹤0.01% 2906
2016
Q3
$3.3M Hold
4,022
﹤0.01% 2857
2016
Q2
$3.35M Sell
4,022
-915
-19% -$764K ﹤0.01% 2849
2016
Q1
$4.54M Hold
4,937
﹤0.01% 2712
2015
Q4
$5.08M Sell
4,937
-153
-3% -$154K ﹤0.01% 2717
2015
Q3
$4.8M Buy
+5,090
New +$5.31M ﹤0.01% 2744

Other funds holding AGN.PRA

BlackRock Institutional Trust's AGN.PRA Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Allergan plc (AGN.PRA) stake by 1.5% in Q4 2016, selling an estimated $46.9K and leaving 3,960 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2906.

BlackRock Institutional Trust first reported a position in AGN.PRA in Q3 2015 and has held it in 6 quarters since. The position peaked at $5.08M in Q4 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

  • BlackRock Institutional Trust held 3,960 shares of Allergan plc worth $3.02M as of Q4 2016.
  • BlackRock Institutional Trust sold 62 Allergan plc shares in Q4 2016, an estimated $46.9K.
  • Allergan plc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2906 holding.
  • BlackRock Institutional Trust first reported a position in Allergan plc in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Allergan plc position peaked at $5.08M in Q4 2015.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.